Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Cancers × X-Rays × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 23 Prostatic Neoplasms 20 Carcinoma, Non-Small-Cell Lung 15 Sarcoma 12 Multiple Myeloma 12 Breast Neoplasms 10 Lymphoma, Non-Hodgkin 9 Wilms Tumor 8 Osteosarcoma 8 Neuroblastoma 8 Leukemia, Myeloid, Acute 8 Glioma 8 Rhabdoid Tumor 7 Ovarian Neoplasms 7 Neoplasm Metastasis 7 Hepatoblastoma 7 Colorectal Neoplasms 7 Carcinoma, Hepatocellular 7 Rhabdomyosarcoma 6 Rectal Neoplasms 6 Neuroectodermal Tumors, Primitive, Peripheral 6 Myelodysplastic Syndromes 6 Mouth Neoplasms 6 Medulloblastoma 6 Histiocytosis, Langerhans-Cell 6 Ependymoma 6 Sarcoma, Ewing 5 Pancreatic Neoplasms 5 Melanoma 5 Lymphoma, Large B-Cell, Diffuse 5

Interventions

Surveys and Questionnaires 4 pazopanib 3 Erlotinib Hydrochloride 3 Cetuximab 3 Vorinostat 2 Oxaliplatin 2 Bevacizumab 2 Azacitidine 2 satraplatin 1 ridaforolimus 1 ixazomib 1 X-Rays 1 Videotape Recording 1 Valproic Acid 1 Trastuzumab 1 Sugars 1 Sorafenib 1 Platinum 1 Pemetrexed 1 Magnetic Resonance Spectroscopy 1 Leucovorin 1 Lenalidomide 1 Lapatinib 1 LY 2275796 1 Injections, Subcutaneous 1 Fluorouracil 1 Everolimus 1 Curcumin 1 Crizotinib 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01432119 2013-04-09

Phase 1 Trial With SIR-Spheres and Cetuximab +/- Erlotinib

M.D. Anderson Cancer Center

Phase 1 Withdrawn

Advanced Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡